3.75 WATSON 363 (Clorazepate 3.75 mg)
Pill imprint 3.75 WATSON 363 has been identified as Clorazepate dipotassium 3.75 mg.
Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 3.75 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Images for 3.75 WATSON 363 (Clorazepate 3.75 mg)
- 3.75 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- 4 - Some potential for abuse
- Watson Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|63874-1242||Altura Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
Clorazepate dipotassium is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...